Advertisement

Topics

Novo Nordisk increased operating profit in Danish kroner by 57% in the first six months of 2015 to DKK 26.3 billion

03:31 EDT 6 Aug 2015 | GlobalNewsWire (2014)

This article has expired, however you can still download the PDF.
Preview:
16% local currency operating profit growth adjusted for the NNIT divestment Sales increased by 25% in Danish kroner and by 9% in local currencies to DKK 52.3 billion.  Sales of Victoza® increased by 41% (22% in local currencies). Sales of Levemir...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Novo Nordisk increased operating profit in Danish kroner by 57% in the first six months of 2015 to DKK 26.3 billion"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...